Brian Goff serves as the Chief Executive Officer of Agios Pharmaceuticals, guiding the biopharmaceutical enterprise through its strategic evolution in the rare disease therapeutic sector. Bringing over thirty years of extensive leadership experience across major healthcare organizations, Goff has focused on advancing targeted therapies for patients facing severe, underserved medical conditions. Under his direction, the company has concentrated on expanding its innovative clinical pipeline, optimizing commercial operations, and fostering strong collaborative networks with patient advocacy communities to streamline drug development and delivery worldwide.